Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxypropyl methylcellulose (HPMC), also known as hypromellose, is a semi-synthetic, inert, viscoelastic polymer derived from cellulose (PubChem CID 21239). It is widely utilized in the pharmaceutical industry as both an active ingredient in ophthalmic lubricants and a versatile excipient in oral drug delivery systems (FDA Inactive Ingredient Database). As a topical lubricant, it serves as a tear substitute to treat dry eye syndrome by increasing the residence time of moisture on the ocular surface and forming a protective film (StatPearls, Dry Eye Syndrome). In oral formulations, it acts as a binder, film-coater, and hydrophilic matrix for controlled-release medications, modulating drug dissolution through its gel-forming properties (ScienceDirect, Hydroxypropyl Methylcellulose). Because its therapeutic effects are mediated through physical and mechanical actions rather than binding to a specific protein or signaling pathway, it is not considered a molecular target in the traditional pharmacological sense. Its primary value lies in its ability to modify the rheological properties of solutions and provide a physical barrier or delivery vehicle for other active pharmaceutical ingredients.
Hypromellose acts as a physical lubricant and viscosity-increasing agent. In ophthalmic applications, it stabilizes the precorneal tear film and increases tear residence time by forming a transparent, lubricating, and protective film on the corneal surface (PubChem CID 21239). In oral drug delivery, it forms a hydrophilic gel matrix upon contact with water, which controls the rate of drug release through diffusion and erosion (ScienceDirect, Hydroxypropyl Methylcellulose).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxypropyl methylcellulose (Hypromellose) (HPMC).